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Abstract 
Background: Liver resection is the mainstay of treatment for most of the liver tumors. Liver has a unique capability 
to restore the lost volume following resection, however, most of the primary tumors grow in a liver with preexisting 
parenchymal diseases and secondary tumors often present in multiple liver lobes precluding a safe curative resection. 
Two-stage hepatectomy and portal vein ligation (PVL) are used to achieve a safer future remnant liver volume (FRLV), 
however, these procedures take several weeks to achieve adequate FRLV. A recently introduced faster alternative 
two-stage hepatectomy, also know as associated liver partitioning and portal vein ligation for staged hepatectomy 
(ALPPS), produces a desirable FRLV in days.
Methods: To have an insight into the mechanism of ALPPS associated liver regeneration, we reproduced a rat model 
of ALPPS and compared the results with the PVL group.
Results: Our results convincingly showed an advantage of the ALPPS procedure over PVL group in terms of early 
regeneration, however, in 1-week time the amount of regeneration was comparable. An early regeneration in the 
ALPPS group coincided with an early entry of hepatocytes into the cell proliferation phase, a significant increase in 
portal pressure and increase in hepatic enzymes in the ALPPS group compared with the PVL group. According to the 
protein array evaluation of 29 cytokines/chemokines, cytokine induced neutrophil chemoattractant-1 had the highest 
expression whereas IL-6 had the highest fold (>6 vs PVL group) expression at the early phase of regeneration in the 
ALPPS group.
Conclusions: This unique rat model of ALPPS would help to improve our understanding about the liver generation 
process and also will help in further refinement of the ALPPS procedure for the clinical benefit.
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Background
With the advent of improved perioperative manage-
ment, liver resection is getting a newer dimension with 
increasing number of extended hepatic resections at low 
morbidity and mortality rates. According to the cur-
rent guidelines, approximately 75  % of the liver can be 
removed safely without increasing the risk of post-oper-
ative liver failure in patients with healthy liver, however, 
this decreases when the remnant liver is not healthy [1]. 
This rule could be applied to patients presenting with a 
well demarcated tumor(s) confined in a specified ana-
tomical zone and/or without any preexisting parenchy-
mal liver diseases. However, most of the patients with 
primary liver tumor already have some sort of preexisting 
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liver parenchymal diseases such as cirrhosis and those 
with secondary tumors, often present with tumors scat-
tered over multiple liver lobes precluding a straight for-
ward line of resection and preservation of an adequate 
future remnant liver volume (FRLV). Excessive removal 
of liver parenchyma or an inadequate FRLV often cul-
minates in postoperative morbidity and even death from 
liver failure [2].
Unlike other vital organs in the body, only liver sieves 
the gut originated portal flow before draining it out into 
the systemic circulation pointing towards a vital role of 
portal blood flow in sustaining normal liver function 
and growth. It has been well recognized that diverting 
portal blood flow by placing a portacaval shunt below 
the liver causes liver atophy [3]. In 1986, Kinoshita et al. 
first exploited this concept in humans and was success-
fully able to induce atrophy of the tumor bearing side of 
the liver by portal vein embolization with simultaneous 
compensatory hypertrophy of the FRL [4]. This paradigm 
has reined the strategy to increase the preoperative FRL 
volume for the last two decades with mixed outcomes. 
The main drawback of this approach, however, has been 
the time required to achieve an adequate increase of the 
FRLV. Usually it takes 3–12 weeks to achieve adequate 
FRLV following PVE, which often proved too long due 
to the unrestricted tumor growth [5]. This has prompted 
the surgeons to rethink about some alternative strate-
gies including the staged hepatectomies. Very recently, 
Schnitzbauer et  al. [6] has pioneered a new strategy of 
two-staged approach to achieve faster growth of FRL by 
combining the portal vein ligation and parenchymal par-
titioning between the ligated and non-ligated part of the 
liver which ideally prevents cross collateral flow between 
the lobes and increases the pace of the growth of the FRL. 
This procedure was later acronymed as associated liver 
partitioning and portal vein ligation for staged hepatec-
tomy (ALPPS). The ALPPS procedure is still in it’s evolv-
ing stage and although it significantly improves the pace 
of the growth of the FRLV, however, preliminary reports 
indicate that it comes at a cost of increased postopera-
tive morbidity and mortality justifying further improve-
ment or modification of the technique [7, 8]. Therefore, 
it is worth to reproduce the ALPPS in an animal model 
to study the actual mechanism of the accelerated regen-
eration, refine the procedure and find ways to further 
improve it. To that end, we herein describe for the first 
time an animal model of ALPPS in rats and evaluated 
possible mechanism(s) of enhanced liver regeneration.
Methods
Animals
Male Sprague–Dawley rats, 6–8  weeks old and weigh-
ing between 200 and 250  g, were obtained from the 
Charles-River Laboratories UK Ltd. The animals were 
housed in a temperature controlled room (23  ±  2  °C), 
with a relative humidity of 50 ± 10 % and alternate light 
and dark conditions. They were given standard labora-
tory rodent chow. All animal experiments were con-
ducted according to the Home Office guidelines under 
the UK Animals and Scientific Procedures Act 1986.
Experimental group
The experiment was conducted in three groups of ani-
mals; (1) Sham group: abdomen was opened and closed 
after manipulation of the liver hilum, (2) PVL group: 
selective portal vein ligation of all branches except the 
branch to the right median lobe was done and (3) ALPPS 
group: selective portal vein ligation and liver parenchy-
mal partitioning were done. Each group consisted of 6 
rats and there were four time points including 24 h, 48 h, 
96 h and 1 week.
Surgical operation
Following the preoperative preparation, the skin was 
cleaned with iodine and 70 % alcohol. 2 % isoflurane with 
oxygen was used to induce anesthesia. Abdomen was 
opened through a midline incision and all hepatic liga-
ments were severed to free the liver. With the help of an 
operating microscope (Leica Wild M691, Wetzlar, Ger-
many), hepatic hilum was inspected and all blood vessels 
including the portal branches and arteries were identi-
fied. Individual portal branches including the right por-
tal vein, caudate branch, left median branch and the left 
lateral portal vein were dissected free from the arteries 
and were ligated near the pedicle with 7-0 nylon sutures 
(Fig. 1a, b). In the ALPPS group, in addition to the por-
tal vein ligation the median lobe was transected along 
the vascular demarcation line visible following the PVL, 
which was immediately right to the median fissure of 
the median liver lobe (Fig. 1b). Parenchymal transection 
was achieved by ligating all vessels in the transection line 
with the help of 4-0 vicryl sutures and hemostasis was 
achieved by using hemoclips and diathermy cauteriza-
tion. A bulldog clamp was applied briefly (3–4 min) near 
the hepatic pedicle (Pringle maneuver) to reduce the 
amount of blood loss during the parenchymal transec-
tion. A similar Pringle maneuver was also applied in the 
Sham and PVL groups.
All animals received 0.5  ml intraperitoneal normal 
saline before closure of the abdomen. Animals were 
allowed to recover in a heated (35  °C) chamber until 
they regained their consciousness and then were kept 
in a recovery room with heat pad under the cages for 
24 h after the surgical operation. Body weight of all ani-
mals was monitored regularly. After 24 h, 48 h, 96 h, and 
1 week time, animals were humanely killed. Immediately 
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before killing, portal pressure was measured by inserting 
a 25G needle directly into the main trunk of the portal 
vein which was connected to a transducer pressure moni-
toring system [Powerlab (4SP) and Chart v5.0.1 software, 
ADInstruments Pty.Ltd, UK]. The pressure reading was 
taken in stable hemodynamic condition and for each 
reading the pressure was recorded over 1  min and the 
average was taken as the final pressure reading. Blood 
samples were collected from the abdominal aorta and the 
whole liver was dissected out for measurement of total 
liver weight and then individual lobes were dissected and 
weighed separately. Liver tissue samples were preserved 
in liquid nitrogen and also in 10 % buffered formalin for 
further use.
Proteome profiler rat liver tissue cytokine array
We used a cytokine array system (Proteome Profiler Rat 
Cytokine Array; ARY008, R&D Systems, Minneapolis, 
MN, USA) to study the expression of multiple cytokines 
in liver tissue samples collected at different time points 
following the surgery. Briefly, 600 μg of pooled liver tis-
sue homogenate collected from the same group was incu-
bated with the array antibody cocktail provided with the 
kit and incubated for 1  h at room temperature before 
adding the sample to the array membrane preincubated 
with the blocking buffer and incubation overnight at 4 °C. 
Subsequently, the array membrane was incubated with 
the Streptavidin-HRP antibody for 30 min at room tem-
perature and chemiluminescent detection reagent mix 
for 1 min. In between steps, the membrane was washed 
three times for 10 min each. The chemiluminescent sig-
nal was read by a image grabber (FluorChem M system, 
ProteinSimple, Santa Clara, California) and the data were 
analyzed with the MyImage analysis software (Thermo 
Fisher Scientific, USA). The pixel data were subtracted 
from the background noise and normalized by the refer-
ence values.
Blood biochemistry
Plasma samples were used to measure the hepatic 
enzymes and liver function tests by using an automated 
clinical chemical analyzer (Roche P Module analyzer). All 
reagents and calibrators were supplied by Roche Diag-
nostics Limited, Charles Avenue, Burgess Hill, West Sus-
sex, RH 15 9RY, UK.
Routine histopathology and Immunohistochemistry
Paraffin embedded tissue sections were used for the 
hematoxylin and eosin staining. Immunostaining was 
performed by using a commercially available kit (Vector 
Fig. 1 Experimental schema is shown. Upper panel is showing the liver at 1-week time point in different groups(a PVL, b ALPPS, and c Sham); the 
median lobes are encircled with yellow line. The lower panel shows the ligated portal branches (red line) and the parenchymal transection line is 
shown in red interrupted line in the ALPPS group (b)
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Laboratories, UK). Briefly, the slides were dewaxed in 
xylene, rehydrated in graded alcohol and rinsed in phos-
phate buffer solution (PBS) for 5  min. Antigen retrieval 
was done by immersing the slides in citrate buffer solu-
tion (pH 6.0, Dako, UK) and autoclaved for 15  min. 
Endogenous peroxidase activity was quenched by incu-
bating the slides with 3 % hydrogen peroxide for 20 min. 
Following incubation with the blocking serum, the sec-
tions were incubated with anti-Ki-67primary antibody 
(monoclonal mouse anti-ki-67 antibody; Abcam, UK) 
overnight at 4  °C. Goat anti-mouse secondary antibody 
conjugated with IgG-HRP was applied for 30 min. Color 
development was done with the peroxidase substrate 
3-amino-9-ethylcarbazole. Between steps, slides were 
rinsed with PBS. Counterstaining of nucleus was done 
with Mayer’s hematoxylin solution.
Statistical analyses
All data are reported as mean  ±  SEM. Differences 
between groups were compared by unpaired t test or 
Mann–Whitney U test as appropriate. For comparison 
of multiple groups, one-way ANOVA with Turkey’s HSD 
posthoc test was used. Statistical significance was taken 
as p < 0.05 by SPSS software, version 22.
Results
All animals survived the procedure and had smooth 
recovery during the postoperative period. However, 
as shown in the Additional file  1: Figure  1, during our 
pilot study, we occasionally noticed necrotic changes 
along the partitioning line in the liver and also in the left 
median lobe (LML), which represents a similar occur-
rence in patients following ALPPS operation. The whole 
liver weight/body weight ratio was marginally higher in 
the ALPPS group when compared with the PVL and the 
Sham groups, however, there was no statistical differ-
ences among the groups (data not shown).
There were steady and significant increases in the FRLV 
over the time period in both ALPPS and PVL groups. 
Compared with the Sham livers, the ratio of FRLV/BW 
increased 54.0, 78.2, 139.8 and 198.9  % in the ALPPS 
group and, 5.1, 44.9, 86.8 and 209.4 % in the PVL group at 
24 h, 48 h, 96 h and 1 W, respectively (Fig. 2a, b). When 
compared with the PVL group, significant increases in 
the FRLV/BW ratio were noticed in the ALPPS group 
at 24  h (p  =  0.024, ANOVA/Turkey HSD) and 96  h 
(p  =  0.001, ANOVA/Turkey HSD) time periods and it 
was almost similar in both groups at 1 week time period 
(Fig.  2). A contemporary atrophy of the ligated lobes 
including the LML was more pronounced in the PVL 
group than in the ALPPS group (data not shown).
Early peak levels in both serum aspartate aminotrans-
ferase (AST) and Alanine aminotransferase (ALT) levels 
were noticed at 24 h in the ALPPS group (AST, p = 0.054 
and ALT, p = 0.000 vs. PVL group ANOVA/Turkey HSD 
test) whereas in the PVL group, the peaks were at 48  h 
for both enzymes (AST, p =  0.000 and ALT, p =  0.000, 
ANOVA/Turkey HSD test) (Fig.  3). Both enzymes 
retuned to almost normal level at 96 h postoperatively.
Next, we looked at the proliferative index (PI) of the 
liver at different time intervals as assessed by counting 
the number of Ki-67 positive nuclei per high power field 
(×100). Two individual authors who were blinded about 
the groupings did the counting and an average was con-
sidered as the final count. The number of cells in three 
high power fields (×100) were counted and the data was 
expressed as PI. Increased PI was noticed in the ALPPS 
group when compared with the PVL group through-
out the experimental period and was significant only at 
24 h (p = 0.002, t test) and 48 h (p = 0.031, t test) time 
points (Fig.  4). The inflammatory cells were counted 
in three high power fields(×100) in mostly populated 
areas and an average was considered as the final count 
for each section. The histopathological examination of 
H&E stained sections showed higher infiltration of liver 
by inflammatory cells in the ALPPS group at initial time 
periods (ALPPS vs PVL: 68 ± 23 and 79 ± 43 vs 37 ± 19 
58 ± 36 at 24 & 48 h, p = 0.021 and 0.380, respectively) 
when compared with the PVL group, which was partially 
resolved at later time periods (Fig. 5). There was hetero-
geneity in the extent of infiltration with more infiltration 
closer to the line to partitioning and less away from the 
line.
The average portal pressure (PP) in the Sham 
group was 8.48  ±  1.19, 8.76  ±  0.95, 7.89  ±  0.37 and 
8.14 ± 0.58 mmHg, at 24 h, 48 h, 96 h and 1 W, respec-
tively (Additional file  2: Figure  2). Overall, the PP was 
highest in the ALPPS group at all time points except 
at 96  h and it was significantly higher in the ALPPS 
group only at 24 h when compared with the PVL group 
(ALPPS vs. PVL: 12.90 ± 1.32 vs. 10.04 ± 2.00, p = 0.025, 
11.82 ± 2.11 vs. 10.60 ± 1.04, p = 0.210, 10.44 ± 2.05 vs. 
10.76 ± 1.89, p = 0.766 and 12.03 ± 1.52 vs. 9.54 ± 2.06, 
p = 0.129, at 24 h, 48 h, 96 h and 1 W, respectively).
To evaluate the possible mechanism of early regen-
erative response in the ALPPS group, next we looked 
at the expression of a battery of cytokines/chemokines 
and growth factors at the tissue level. We used a pro-
teome array kit to examine the expression profile of 29 
cytokines/cytokines in liver tissue samples. The list of 
the proteins with their mean OD values is shown in 
Additional file  3: Table  S1. We have divided them into 
early responsive or late responsive proteins depending 
on whether the expression of the proteins in the ALPPS 
group was higher at 24 or 48  h time points. Figure  6 
shows the mean optical density (OD) values of the 
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proteins whose expressions in the ALPPS group were 
more than twice than the expression in the PVL group. 
Among all of the cytokines, the cytokine-induced neu-
trophil chemoattractant -1 (CINC-1) had the strongest 
expression whereas the largest difference in expression 
between the ALPPS and PVL group was in interleukin-6 
(IL-6) expression with more than 6-fold higher expres-
sion in the ALPPS group than in the PVL group at 24 h. 
Besides IL-6 and CINC-1, (interleukin-2)IL-2, (inter-
leukin-13) IL-13 and macrophage inflammatory protein 
1alpha (MIP-1a) expressions were higher(>2 fold) in the 
ALPPS group at 24 h time point than in the PVL group 
Fig. 2 The left panel (a) is showing the macroscopic views of the explanted livers at different time points in the ALPPS and the PVL group. The right 
panel (b) is showing the ratio of the FRL (right median lobe)/body weight (FRL/BW) ratio. Significant increases in the FRL/BW ratio was noticed at 24 
and 96 h time points in the ALPPS group compared with the PVL group
Fig. 3 Hepatic enzyme (AST & ALT) levels are shown. Both enzymes had peak at 24 h time point in the ALPPS group whereas the peaks were at 
48 h in the PVL group
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(Fig.  6a). In contrast, only granulocyte macrophage col-
ony stimulating factor (GM-CSF) had more than 2-fold 
expression in the PVL group than in ALPPS group at 
24  h. Also we noticed expression of granulocyte mac-
rophage colony stimulating factor (GM-CSF), vascular 
endothelial growth factor (VEGF) and interferon gamma 
(IFN-g) with late peaks at 48 h in the ALPPS group when 
compared with the PVL group (Fig. 6b).
Discussion
The ALPPS concept of inducing fast-track liver regenera-
tion might be one of the finest surgical marvels in the field 
Fig. 4 The proliferative index (PI) is shown in panel a, significant increase in PI was noticed at 24 and 48 h time points in the ALPPS group when 
compared with the PVL group. Panel b shows the immenohistochemical staining of Ki-67 in the ALPPS and the PVL group, Ki-67 stained cells were 
noticed near the portal tract area in the early time point (24 h) and dispersed all over the hepatic lobes at 48 h time point (×40)
Fig. 5 Hematoxylin and eosin stained tissue sections are shown. There was significantly higher infiltration of inflammatory cells in the ALPPS group 
at early hours (24 and 48 h) when compared with the PVL group (×40)
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Fig. 6 The top 5 (a) panels show the relative expression of cytokines/chemokines in the liver tissue whose expression were more than twice in the 
ALPPS group than in the PVL group at early hours of liver regeneration (24 h). Whereas bottom three panels (b) show the expression of proteins 
whose expression was more than twice at 48 h time pint in the ALPPS group than in the PVL group
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of liver surgery in recent decades. In this study, we have 
reproduced the clinical concept of ALPPS in a rat model 
and, as far as we are aware, this is the first full report of 
rat ALLPS model. We have convincingly showed that the 
ALPPS procedure steers robust liver regeneration at a 
much faster rate than the PVL alone, however, the PVL 
itself produced comparable amount of liver regeneration 
in the long run at 1 week postoperatively.
During the ALPPS procedure, usually the segments 
2 and 3 are spared as the FRL, which constitute about 
20–25  % of the whole human liver. We choose the rat 
model as the rats are widely used for the liver regen-
erative studies and easily available for the research pur-
poses, however, in rats the liver is lobulated except the 
median lobes which constitutes about 38.17 ± 1.45 % of 
the whole rat liver with approximately 25 % belonging to 
the right median lobe (RML) and 14 % to the left median 
lobe (LML). Therefore, to reciprocate the clinical ALPPS 
model in terms of volume of FRL, we ligated portal 
branches to all liver lobes except the right mead liver lobe 
which constitute approximately 25 % of the rat liver. We 
used the median lobe for the liver parenchymal partition-
ing along a line just right to the falciform ligament. We 
noticed significant regenerative drive of the FRL in the 
ALPPS group at 24  h time point whereas the regenera-
tion kicked off in the PVL group at a later stage at 48 h. 
In the ALPPS group, the FRLV/BW ratio was higher at 
all points when compared with the PVL group except at 
1 W time when the FRLV/BW ratio became almost same 
in both groups.
While this article was in preparation, we noticed 
a report describing the ALPPS model in mice which 
used the left median lobe (13  % of the whole liver) as 
the FRL and also included an additional step of left lat-
eral lobectomy (30  % hepatectomy) in addition to the 
ALPPS procedure [9]. The authors of this article con-
cluded a significant increase in the FRLV/BW ratio in 
the ALPPS group when compared with the PVL group 
and our results concur with their findings, however, 
only at the early stage of the liver regeneration. In our 
model, the FRLV/BW ratio was marginally higher in the 
PVL group when compared with the ALPPS group at 
1 week time point whereas in their study the volume of 
the regenerating lobe was higher in the ALPPS group 
than in the PVL group (p =  0.06). This could be attrib-
utable to the design of their model, which comprised 
of an additional partial hepatectomy (30  %) and ALPPS 
rather than the ALPPS only model which might had an 
additional advantage for the ALPPS group but not for the 
PVL group. In rodents, the left portal vein branch divides 
distally into two branches; the upper one supplies the left 
median lobe and the lower branch supplies the LLL. As 
the LLL branch is embedded into the hilum of the LLL 
parenchyma, therefore, it remains quite challenging 
to selectively ligate this branch without interfering the 
blood supply to the LML and LLL. In a pilot study, we 
tried to selectively ligate the LLL portal branch to cre-
ate a left-sided ALPPS model without removing the LLL, 
however, the results were inconsistent (data not shown). 
From this viewpoint, we prefer the right-sided ALPPS 
model (right median lobe as the FRL) for further evalua-
tion. Also when we were about to submit this article, we 
noticed a brief report on right sided rat ALPPS model 
mentioning significant increase in liver regeneration of 
the FRL at day 3, 7 and 14 but lacking any comparison 
with the PVL group [10]. AS far as we aware, this is the 
first study showing the liver images of the ALPPS regen-
erated lobes in an animal model.
Liver regeneration is a complex procedure involving 
a concerted activity of different kinds of cells including 
the resident liver cells and infiltrating inflammatory cells 
which is triggered by shear stress, cytokines and growth 
factors [11]. The doctrine behind the ALPPS was to pre-
vent the neocollateral formation across the ligated and 
non-ligated liver lobes by adding the liver parenchymal 
partitioning step to the PVL. It seems that the portal vein 
ligation/embolization alone often fails to induce enough 
contralateral hypertrophy because of distal portopor-
tal collateral formation [12] and also in experimental 
study it has been shown that proximal portal vein occlu-
sion causes progressive portal cavernoma and reen-
try of portal blood from the non-occluded lobe to the 
occluded lobe [13]. In this study, we noticed significant 
increase in the portal pressure in the ALPPS group com-
pared with the PVL group, which might have increased 
the shear stress and stimulated early regeneration in the 
ALPPS group. It is worth to mention that Shindoh et al. 
[14] reported a unique way to perform the PVE which 
also includes the segment four producing an equivalent 
FRL hypertrophy compared to the ALPPS, however, at 
a relatively slower rate which the authors consider as an 
advantage over ALPPS from the perspective of detection 
of occult metastatic focus before the 2nd stage operation 
and thus the unnecessary 2nd stage operation could be 
avoided. A comparable liver regeneration at one-week 
time point in both the ALPPS and PVL groups could be 
explained by the unique PVL approach we did in this 
study which includes part of the right median lobe and 
may represent the segment four in human. This needs 
further evaluation in an experimental set up.
In addition to putting a physical barrier to prevent the 
formation of portoportal collateral formation, liver par-
titioning along with the PVL induced cellular apoptosis 
and a sterile inflammatory reaction in the liver followed 
by cytokine surge; which in turn helped in acceler-
ated liver regeneration. In our study, we noticed early 
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increase in inflammatory cell infiltration in the liver 
tissue in the ALPPS group. Similarly, Tanaka et  al. [15] 
mentioned almost twice the number of hepatic kupffer 
cells infiltration following PVE  +  PH than in the PH 
only group which also provided better protection follow-
ing endotoxin challenge in rats. We examined an array 
of cytokines in the liver tissue and, according to the 
kinetics of them we propose a concerted involvement 
of hepatic parenchymal cells, resident non-parenchymal 
cells and infiltrated inflammatory cells in the augmented 
ALPPS liver hypertrophy. It seems that the a concerted 
involvement of immunomodulatory cells including 
the hepatic stellate cells, kupffer cells, macrophages 
and bone marrow derived cells play pivotal roles in the 
liver regeneration. Among the 29 examined cytokines, 
CINC-1 had the strongest and early significant expres-
sion in the ALPPS liver when compared with the PVL 
liver, supporting a crucial role of CINC-1 in the ALPPS 
associated regeneration. Interestingly, Kaibori et al. [16] 
noticed that CINC-1 induced by hepatocyte growth fac-
tor (HGF) produced enhanced proliferative and angio-
genic activities through NFkB activation in the liver. 
Besides CINC-1, we also noticed early significant expres-
sion of IL-6, MIP-1a, IL-2 and IL-13 in the ALPPS group 
which might have played significant role in the ALPPS 
liver regeneration. The increased IL-6 level concords 
with the mice ALPPS study as well, the authors noticed 
a significant increase in plasma IL-6 in the ALPPS group 
compared with the PVL group. It is particularly worth 
to mention that early activation of IL-6/STAT3 path-
way in macrophages is essential for the production of 
chemokines such as MIP-a, which in turn might enhance 
the migration of bone marrow derived MSCs to the 
liver during the restitution of liver mass [17]. In fact, 
we noticed a significant increase in MIP-1a in ALPPS 
liver at 24 h when compared with the PVL group (Aure 
6). These findings are in agreement with the differen-
tial expression pattern and kinetics of cytokines/growth 
factors in PH and PVL. Fujii et al. [18] showed that fol-
listatin, a TGF-B/activin binding protein, accelerated the 
regeneration following PH, however, had no effect on 
regeneration induced by the PVL whereas Mueller et al. 
[19] noticed that the mRNA of cell proliferation marker 
histone2B significantly elevated at 24  h after PH but it 
was delayed at 48 h following PVL. Therefore, our results 
show differential expression of cell proliferation activat-
ing chemokines, specially the CINC-1-MIP1 –IL-6 axis, 
during the early regenerative phase between the ALPPS 
and PVL group, further studies are necessary to modu-
late the expression of particular growth factor such as 
CINC-1 during the ALPPS liver regeneration model in 
the set up of parenchymal liver disease to further aug-
ment liver regeneration.
Liver has a unique capability to regenerate and the 
actual mechanism(s) of the regeneration still remains a 
dilemma. Studying the mechanism of regeneration in the 
ALPPS model would unlock the myth behind the extraor-
dinary capability of the liver for regeneration, which 
would help in designing new therapeutic options for the 
regenerative drive in difficult set up such as chronic liver 
diseases. Although the ALPPS procedure is getting popu-
larity among the surgeons, however, the procedure is still 
in it’s infancy needing further refinement for broader 
clinical application [20]. Following the ALPPS procedure, 
the percent increase in the FRLV ranges from as low as 
21–200 % and, to date, the actual reason of this massive 
variation is not clear. This could be partially attributable 
to the presence of underlying parenchymal liver diseases 
such as metabolic syndrome, cirrhosis and neoadju-
vant treatment related liver diseases such as sinusoidal 
obstruction syndrome. The effect of presence of these 
conditions on ALPPS regeneration may help to improve 
our understanding of ALPPS regeneration and would 
decrease the postoperative morbidity. Also other areas 
which will need attention to further increase the indica-
tion of ALPPS include the natural history of growth of 
micrometastasis in the FRL, role of the atrophic lobe on 
the regeneration of the FRLV, and, chemical, non-invasive 
or minimally invasive liver partitioning are among a few. 
We believe that our ALPPS model in rats would enable 
the researchers to address these unsolved issues related 
to the ALPPS in the future.
Abbreviation
ALPPS: associated liver partitioning and portal vein ligation for staged hepa-
tectomy; FRLV: future remnant liver volume; AST: aspartate aminotransferase; 
ALT: alanine aminotransferase; CINC-1: cytokine-induced neutrophil chemoat-
tractant -1 (CINC-1); IL-6: interleukin-6 (IL-6); PVL: portal vein ligation; IL-2: 
interleukin-2; IL-13: interleukin-13; MIP-1a: macrophage inflammatory protein 
1alpha; GM-CSF: granulocyte macrophage colony stimulating factor; VEGF: 
vascular endothelial growth factor; IFN-g: interferon gamma.
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